DE69207351D1 - Fibrinogen-Rezeptor-Antagoniste - Google Patents
Fibrinogen-Rezeptor-AntagonisteInfo
- Publication number
- DE69207351D1 DE69207351D1 DE69207351T DE69207351T DE69207351D1 DE 69207351 D1 DE69207351 D1 DE 69207351D1 DE 69207351 T DE69207351 T DE 69207351T DE 69207351 T DE69207351 T DE 69207351T DE 69207351 D1 DE69207351 D1 DE 69207351D1
- Authority
- DE
- Germany
- Prior art keywords
- receptor antagonists
- fibrinogen receptor
- fibrinogen
- antagonists
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78448491A | 1991-10-29 | 1991-10-29 | |
US07/821,116 US5272158A (en) | 1991-10-29 | 1992-01-15 | Fibrinogen receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69207351D1 true DE69207351D1 (de) | 1996-02-15 |
DE69207351T2 DE69207351T2 (de) | 1996-10-17 |
Family
ID=27120288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69207351T Expired - Fee Related DE69207351T2 (de) | 1991-10-29 | 1992-10-29 | Fibrinogen-Rezeptor-Antagoniste |
Country Status (5)
Country | Link |
---|---|
US (1) | US5272158A (de) |
EP (1) | EP0540334B1 (de) |
JP (1) | JPH07116144B2 (de) |
CA (1) | CA2081614A1 (de) |
DE (1) | DE69207351T2 (de) |
Families Citing this family (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780303A (en) * | 1990-04-06 | 1998-07-14 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US6521594B1 (en) | 1990-04-06 | 2003-02-18 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5672585A (en) * | 1990-04-06 | 1997-09-30 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US6017877A (en) * | 1990-04-06 | 2000-01-25 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5389631A (en) * | 1991-10-29 | 1995-02-14 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
US5416099A (en) * | 1991-10-29 | 1995-05-16 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
AU675689B2 (en) * | 1992-12-01 | 1997-02-13 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
US5750754A (en) * | 1993-03-29 | 1998-05-12 | Zeneca Limited | Heterocyclic compounds |
AU692439B2 (en) * | 1993-03-29 | 1998-06-11 | Zeneca Limited | Heterocyclic compounds as platelet aggregation inhibitors |
US5753659A (en) * | 1993-03-29 | 1998-05-19 | Zeneca Limited | Heterocyclic compouds |
GB9406143D0 (en) * | 1993-03-29 | 1994-05-18 | Zeneca Ltd | Heterocyclic derivatives |
US5652242A (en) * | 1993-03-29 | 1997-07-29 | Zeneca Limited | Heterocyclic derivatives |
US5463011A (en) * | 1993-06-28 | 1995-10-31 | Zeneca Limited | Acid derivatives |
GB9313268D0 (en) * | 1993-06-28 | 1993-08-11 | Zeneca Ltd | Chemical compounds |
GB9313285D0 (en) * | 1993-06-28 | 1993-08-11 | Zeneca Ltd | Acid derivatives |
EP0725059B1 (de) * | 1993-10-19 | 2001-01-17 | Sumitomo Pharmaceuticals Company, Limited | 2,3-diaminopropionsäurederivate |
CA2134192A1 (en) * | 1993-11-12 | 1995-05-13 | Michael L. Denney | 5, 6-bicyclic glycoprotein iib/iiia antagonists |
US5563158A (en) * | 1993-12-28 | 1996-10-08 | The Dupont Merck Pharmaceutical Company | Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists |
DE4405378A1 (de) * | 1994-02-19 | 1995-08-24 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
US5821241A (en) * | 1994-02-22 | 1998-10-13 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
US5451578A (en) * | 1994-08-12 | 1995-09-19 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
US5525617A (en) * | 1994-08-24 | 1996-06-11 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
US5494921A (en) * | 1994-09-16 | 1996-02-27 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
US5646000A (en) * | 1994-09-29 | 1997-07-08 | Merck & Co., Inc. | Compounds and methods for identifying activated platelets |
US5719144A (en) * | 1995-02-22 | 1998-02-17 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
WO1997011940A1 (en) | 1995-09-29 | 1997-04-03 | Eli Lilly And Company | Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
US5852045A (en) * | 1995-10-19 | 1998-12-22 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
CA2234967A1 (en) * | 1995-10-19 | 1997-04-24 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
ES2185009T3 (es) * | 1996-04-10 | 2003-04-16 | Merck & Co Inc | Antagonistas de alfa y beta 3'. |
US5869487A (en) * | 1996-10-24 | 1999-02-09 | Merck & Co., Inc. | Pyrido 3,4-B!pyrazines for use as thrombin inhibitors |
US5981584A (en) * | 1997-02-06 | 1999-11-09 | Merck & Co., Inc. | Fibrinogen receptor antagonist prodrugs |
KR100565701B1 (ko) * | 1997-07-31 | 2006-03-29 | 우베 고산 가부시키가이샤 | N-아실아미노산 아미드 화합물 및 그의 제조 중간체 |
US6087373A (en) * | 1997-09-23 | 2000-07-11 | Merck & Co., Inc. | Thrombin inhibitors |
US6623981B2 (en) * | 1998-01-27 | 2003-09-23 | Bristol-Myers Squibb Company | Detection of patients at risk for developing integrin antagonist/agonist mediated disease states |
US6204282B1 (en) | 1998-11-30 | 2001-03-20 | Schering Corporation | Benzimidazole compounds that are vitronectin receptor antagonists |
US6239132B1 (en) | 1999-04-23 | 2001-05-29 | Merck & Co., Inc. | Thrombin inhibitors |
WO2000074682A1 (en) | 1999-06-04 | 2000-12-14 | Merck & Co., Inc. | Thrombin inhibitors |
US6429214B1 (en) | 1999-07-21 | 2002-08-06 | Wyeth | Bicyclic antagonists selective for the αvβ3 integrin |
DE10028575A1 (de) | 2000-06-14 | 2002-03-14 | Basf Ag | Integrinliganden |
RU2004118243A (ru) | 2001-11-13 | 2006-01-10 | 3-Дименшенл Фамэсьютикэлс, Инк. (US) | Замещенные 1,4-бензодиазепины и их использование для лечения онкологических заболеваний |
WO2005035495A2 (en) | 2003-10-08 | 2005-04-21 | Nicholas Piramal India Limited | Fibrinogen receptor antagonists and their use |
HUP0600809A3 (en) * | 2006-10-27 | 2008-09-29 | Richter Gedeon Nyrt | New phenylsulfamoyl-benzamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them |
US8247563B2 (en) * | 2006-12-11 | 2012-08-21 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors |
CN101686680B (zh) | 2007-03-09 | 2015-12-09 | 伊沃泰克美国股份有限公司 | 作为p2x7调节剂的双环杂芳基化合物及其用途 |
KR20100005476A (ko) * | 2008-07-07 | 2010-01-15 | 한국과학기술연구원 | T-형 칼슘 채널에 활성을 지닌 신규 아이소인돌리논유도체 및 이의 제조방법 |
BRPI1010974A2 (pt) | 2009-05-22 | 2019-09-24 | Exelixis Inc | benzoxazepinas baseada em inibidores p13k/ m tor contra doenças proliferativas |
BRPI1010896A2 (pt) | 2009-05-26 | 2019-09-24 | Exelixis Inc | benzoxazepinas como inibidores de pi3k/mtor e métodos de seus usos e fabricação |
CN102725290B (zh) | 2009-07-27 | 2016-03-09 | 吉利德科学股份有限公司 | 作为离子通道调节剂的稠合杂环化合物 |
PE20130188A1 (es) | 2009-12-23 | 2013-02-21 | Takeda Pharmaceutical | Pirrolidinonas heteroaromaticas fusionadas como inhibidores de syk |
PT2588197E (pt) | 2010-07-02 | 2015-02-09 | Gilead Sciences Inc | Compostos heterocíclicos fundidos como moduladores do canal de iões |
CN105693645B (zh) | 2011-05-10 | 2018-10-09 | 吉利德科学公司 | 作为离子通道调节剂的稠合杂环化合物 |
US9056873B2 (en) | 2011-06-22 | 2015-06-16 | Takeda Pharmaceutical Company Limited | Substituted 6-aza-isoindolin-1-one derivatives |
TWI478908B (zh) | 2011-07-01 | 2015-04-01 | Gilead Sciences Inc | 作為離子通道調節劑之稠合雜環化合物 |
NO3175985T3 (de) | 2011-07-01 | 2018-04-28 | ||
US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
BR112016007467B1 (pt) | 2013-10-04 | 2022-09-20 | Infinity Pharmaceuticals, Inc | Compostos heterocíclicos e usos dos mesmos |
WO2015051241A1 (en) | 2013-10-04 | 2015-04-09 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
EA031804B1 (ru) | 2014-02-03 | 2019-02-28 | Вайтаи Фармасьютиклз, Инк. | Дигидропирролопиридиновые ингибиторы ror-гамма |
JP6701088B2 (ja) | 2014-03-19 | 2020-05-27 | インフィニティー ファーマシューティカルズ, インコーポレイテッド | Pi3k−ガンマ媒介障害の治療で使用するための複素環式化合物 |
WO2016054491A1 (en) | 2014-10-03 | 2016-04-07 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
HUE042335T2 (hu) | 2014-10-14 | 2019-06-28 | Vitae Pharmaceuticals Inc | ROR-gamma dihidropirrolopiridin inhibitorai |
US9663515B2 (en) | 2014-11-05 | 2017-05-30 | Vitae Pharmaceuticals, Inc. | Dihydropyrrolopyridine inhibitors of ROR-gamma |
US9845308B2 (en) | 2014-11-05 | 2017-12-19 | Vitae Pharmaceuticals, Inc. | Isoindoline inhibitors of ROR-gamma |
EP3331876B1 (de) | 2015-08-05 | 2020-10-07 | Vitae Pharmaceuticals, LLC | Modulatoren von ror-gamma |
EP3350183A1 (de) | 2015-09-14 | 2018-07-25 | Infinity Pharmaceuticals, Inc. | Feste formen von isochinolinonderivaten, herstellungsverfahren, zusammensetzungen damit und verwendungsverfahren dafür |
EP3377482B1 (de) | 2015-11-20 | 2021-05-12 | Vitae Pharmaceuticals, LLC | Modulatoren von ror-gamma |
TW202220968A (zh) | 2016-01-29 | 2022-06-01 | 美商維它藥物有限責任公司 | ROR-γ調節劑 |
WO2017161116A1 (en) | 2016-03-17 | 2017-09-21 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors |
US10919914B2 (en) | 2016-06-08 | 2021-02-16 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
US9481674B1 (en) | 2016-06-10 | 2016-11-01 | Vitae Pharmaceuticals, Inc. | Dihydropyrrolopyridine inhibitors of ROR-gamma |
US10357493B2 (en) | 2017-03-10 | 2019-07-23 | Selenity Therapeutics (Bermuda), Ltd. | Metalloenzyme inhibitor compounds |
US11043823B2 (en) * | 2017-04-06 | 2021-06-22 | Tesla, Inc. | System and method for facilitating conditioning and testing of rechargeable battery cells |
WO2019018975A1 (en) | 2017-07-24 | 2019-01-31 | Vitae Pharmaceuticals, Inc. | INHIBITORS OF ROR GAMMA |
CN115650976A (zh) | 2017-07-24 | 2023-01-31 | 生命医药有限责任公司 | RORγ的抑制剂 |
US10513515B2 (en) | 2017-08-25 | 2019-12-24 | Biotheryx, Inc. | Ether compounds and uses thereof |
US11236103B2 (en) | 2018-07-27 | 2022-02-01 | Biotheryx, Inc. | Bifunctional compounds |
WO2021222150A2 (en) | 2020-04-28 | 2021-11-04 | Anwita Biosciences, Inc. | Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3322631A (en) * | 1965-06-30 | 1967-05-30 | Merck & Co Inc | Method of treatment of hypertension |
US4010274A (en) * | 1973-07-27 | 1977-03-01 | Carlo Erba | Isoindoline derivatives having platelet anti-aggregating activity |
DE2549999A1 (de) * | 1975-11-07 | 1977-05-12 | Boehringer Mannheim Gmbh | Piperidin-derivate und verfahren zu ihrer herstellung |
US4064125A (en) * | 1976-10-29 | 1977-12-20 | E. R. Squibb And Sons, Inc. | Substituted amides having antiinflammatory activity |
IL60129A0 (en) * | 1979-05-23 | 1980-07-31 | Wuelfing J Kg | Phenylsulphonamide derivatives,their preparation and pharmaceutical compositions containing them |
KR880007441A (ko) * | 1986-12-11 | 1988-08-27 | 알렌 제이.스피겔 | 스피로-치환된 글루타르아미드 이뇨제 |
GB8705601D0 (en) * | 1987-03-10 | 1987-04-15 | Erba Farmitalia | Oxo-isoindolinyl derivatives |
FR2628425B1 (fr) * | 1988-03-08 | 1992-04-03 | Rhone Poulenc Sante | Derives d'isoindolinone, leurs procedes de preparation et les medicaments les contenant |
US4879313A (en) * | 1988-07-20 | 1989-11-07 | Mosanto Company | Novel platelet-aggregation inhibitors |
US5039805A (en) * | 1988-12-08 | 1991-08-13 | Hoffmann-La Roche Inc. | Novel benzoic and phenylacetic acid derivatives |
US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
CA2008116C (en) * | 1989-02-23 | 2001-11-20 | Thomas Weller | Glycine derivatives |
NZ234264A (en) * | 1989-06-29 | 1993-05-26 | Warner Lambert Co | N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives, and pharmaceutical compositions |
-
1992
- 1992-01-15 US US07/821,116 patent/US5272158A/en not_active Expired - Fee Related
- 1992-10-28 JP JP4330875A patent/JPH07116144B2/ja not_active Expired - Lifetime
- 1992-10-28 CA CA002081614A patent/CA2081614A1/en not_active Abandoned
- 1992-10-29 DE DE69207351T patent/DE69207351T2/de not_active Expired - Fee Related
- 1992-10-29 EP EP92309924A patent/EP0540334B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH07116144B2 (ja) | 1995-12-13 |
EP0540334A1 (de) | 1993-05-05 |
JPH05262731A (ja) | 1993-10-12 |
CA2081614A1 (en) | 1993-04-30 |
US5272158A (en) | 1993-12-21 |
EP0540334B1 (de) | 1996-01-03 |
DE69207351T2 (de) | 1996-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69207351D1 (de) | Fibrinogen-Rezeptor-Antagoniste | |
MX9101311A (es) | Antagonistas receptores de fibrinogeno | |
DK0612244T3 (da) | Endothelinreceptorantagonister | |
FI961804A (fi) | Endoteliinireseptoriantagonistit | |
DE69327720T2 (de) | Endothelin rezeptor antagonisten | |
DE69202186D1 (de) | N-substituierte-4-Phenyl-Piperidin-Opioid Antagoniste. | |
EP0673247A4 (de) | Fibrinogen rezeptor antagonisten. | |
EP0667773A4 (de) | Fibrinogen-rezeptor-antagonisten. | |
GB9405317D0 (en) | Fibrinogen receptor antagonists | |
LV5806B4 (lv) | LHL antagonisti | |
MX9100717A (es) | Antagonistas de la bradiquinina | |
ATE213156T1 (de) | Endothelin-rezeptor-antagonisten | |
KR960700722A (ko) | 피브리노겐 수용체 길항제(Fibrinogen receptor antagonists) | |
KR950703530A (ko) | 5-HT4 길항제(5-HT4 Antagonists) | |
NO179550C (no) | Tachykinin reseptorantagonister | |
FI951798A0 (fi) | Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina | |
FI930108A (fi) | Imidazopyridin-paf-antagonister | |
LV10425A (lv) | Fibrinogena receptoru antagonisti | |
ZA917693B (en) | Fibrinogen receptor antagonists | |
DE69004827D1 (de) | Alpha-adrenergene Rezeptor-Antagonisten. | |
CS294891A3 (en) | Fibrinogen receptor antagonists | |
LV5746A4 (lv) | Jauni sulfonamidu fibrinogena receptora antagonisti | |
ZA917694B (en) | Novel fibrinogen receptor antagonists | |
LTIP475A (en) | Fibrinogen receptor antagonists | |
HU9402431D0 (en) | Novel sulfonamide fibrinogen receptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |